Back to Main
 Faculty Listing
Total Records: 4504
Last Name First Name Research/Clinical Interest Title Keywords
KHAN ASAD
KHAN MASOOD
KHAN MINA
KHAN WALID
KHANAL SAFAL
KHARLAMPIEVA EUGENIA stimuli-responsive polymers, drug delivery, cell surface engineering, protein assembly at interfaces
KHASS MOHAMED
KHATRI SNEHAL
KHODNEVA YULIA
KHOURY CHARLES
KIEDROWSKI MEGAN
KILGO JENNIFER
KILLIAN JOHN
KILPATRICK KARA
KIM BRANDON
KIM HAROLD
KIM HYUNG-GYOON making murine models of Human AML (Acute Myeloid Leukemia) caused by chromosomal translocaitons such as inv(16) or AML-1/ETO
KIM JEONGA Cross-talk between inflammation and insulin signaling Insulin Resistance, Endothelial Dysfunction, NO, ROS, Polyphenol
KIM JEONGA Cross-talk between inflammation and insulin signaling Insulin Resistance, Endothelial Dysfunction, NO, ROS, Polyphenol
KIM MANSE
KIM ROBERT
KIM TEAYOUN
KIM YOUNG-IL
KIM YU SHIN
KIMBERLIN DAVID Antiviral therapies of pediatric infections herpes simplex virus, cytomegalovirus, antiviral therapy, clinical trial design
KIMBERLY ROBERT Autoimmunity, Molecular Mechanisms and Genetic Risk autoimmunity, immune-mediated inflammatory disease, Fc receptors, single nucleotide polymorphisms, immunogenetics, functional genomics
KIMBERLY ROBERT Autoimmunity, Molecular Mechanisms and Genetic Risk autoimmunity, immune-mediated inflammatory disease, Fc receptors, single nucleotide polymorphisms, immunogenetics, functional genomics
KIMBERLY ROBERT Autoimmunity, Molecular Mechanisms and Genetic Risk autoimmunity, immune-mediated inflammatory disease, Fc receptors, single nucleotide polymorphisms, immunogenetics, functional genomics
KIMBERLY ROBERT Autoimmunity, Molecular Mechanisms and Genetic Risk autoimmunity, immune-mediated inflammatory disease, Fc receptors, single nucleotide polymorphisms, immunogenetics, functional genomics
KIMBERLY ROBERT Autoimmunity, Molecular Mechanisms and Genetic Risk autoimmunity, immune-mediated inflammatory disease, Fc receptors, single nucleotide polymorphisms, immunogenetics, functional genomics
KINARD BRIAN
KING KATHRYN
KING KELSEY
KING MATTHEW
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING PETER 1) RNA Regulation of Inflammation in ALS and other Neurodegenerative Disorders, 2) Smads as Biomarkers of ALS Disease Progressionh RNA stability; AU-rich elements; cytokines and chemokines; glioblastoma; amyotrophic lateral sclerosis, stroke, spinal cord injury, HuR, KSRP
KING RODNEY Development and maintenance of humoral immunity
KING STEVEN
KINGSLEY JENNIFER
KINSEY AMBER
KIRAN FNU
KIRBY EMILY
KIRBY TYLER
KIRKLAND KALE
KISER CARIN
KISHORE SANJAY
KISSEL REBECCA
KITCHENS DAVID
KIYONO HIROSHI
KLASNER ANN
KLEIN ADAM
KLEIN WRIGHT RACHEL
KLINE LANNING
KLINGER ANDREW
KLODA DAVID
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KLUG CHRISTOPHER Hematopoietic stem cell biology, acute leukemia, and pancreatic cancer
KMEID MICHEL
KNIGHT ALYSSA
KNIGHT AMY
KNIGHT CANDACE
KNIGHT DAVID
KNIGHT JOHN Oxalate Handling and Synthesis and its Relationship to Health and Disease Calcium oxalate kidney stone disease, Oxalobacter formigenes, primary hyperoxaluria
KNIGHT JOHN Oxalate Handling and Synthesis and its Relationship to Health and Disease Calcium oxalate kidney stone disease, Oxalobacter formigenes, primary hyperoxaluria
KNIGHT JOHN Oxalate Handling and Synthesis and its Relationship to Health and Disease Calcium oxalate kidney stone disease, Oxalobacter formigenes, primary hyperoxaluria
KNIGHT STEPHEN
KNOX ROBERT
KOBIE JAMES
KOEHLER ROBERT
KOLE ADAM
KOLE LAUREN
KOLETTIS PETER
KOMOLAFE BABATUNDE
KONARI FATHIMA REJULIN
KONDA RAGHUNANDAN
KONG MICHELE
KOOMULLIL ROY
KOOPMAN WILLIAM
KOPECKY KIMBERLY
KOPF ROBERT
KOPF SABRINA
KORF BRUCE Neurofibromatosis Type 1 neurofibromatosis; neurogenetics; molecular diagnosis, genomic medicine
KORF BRUCE Neurofibromatosis Type 1 neurofibromatosis; neurogenetics; molecular diagnosis, genomic medicine
KORF BRUCE Neurofibromatosis Type 1 neurofibromatosis; neurogenetics; molecular diagnosis, genomic medicine
KORF BRUCE Neurofibromatosis Type 1 neurofibromatosis; neurogenetics; molecular diagnosis, genomic medicine
KORF BRUCE Neurofibromatosis Type 1 neurofibromatosis; neurogenetics; molecular diagnosis, genomic medicine
KORF BRUCE Neurofibromatosis Type 1 neurofibromatosis; neurogenetics; molecular diagnosis, genomic medicine
First Prev   18 19 20 21 22 23 24 25 26 27 of  46  Next Last